Literature DB >> 24135660

Platelet function and genetic testing.

Dominick J Angiolillo, José Luis Ferreiro, Matthew J Price, Ajay J Kirtane, Gregg W Stone.   

Abstract

Keywords:  CYP2C19; antiplatelet; clopidogrel; genetics; platelet function; prasugrel; ticagrelor

Mesh：

Year:  2013        PMID： 24135660     DOI： 10.1016/j.jacc.2013.08.704

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

1.  Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record.

Authors:  Adam A Nishimura; Peter Tarczy-Hornoch; Brian H Shirts
Journal:  Curr Genet Med Rep       Date:  2014-12-01

2.  Evaluation of platelet reactivity using P2Y12 reaction units in acute coronary syndrome with essential thrombocythemia: A case report.

Authors:  Naofumi Yoshida; Noritoshi Hiranuma; Taira Ninomaru; Yuichi Nagamatsu; Naoki Tamada; Tatsuya Miyoshi; Yoshihiro Sasaki; Gaku Kanda; Noriyasu Kobayashi; Takashi Fujii
Journal:  J Cardiol Cases       Date:  2015-04-13

3.  Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts.

Authors:  Adam A Nishimura; Brian H Shirts; Joseph Salama; Joe W Smith; Beth Devine; Peter Tarczy-Hornoch
Journal:  Int J Med Inform       Date:  2015-11-11       Impact factor: 4.046

Review 4.  Novel antiplatelet agents in acute coronary syndrome.

Authors:  Francesco Franchi; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2014-10-07       Impact factor: 32.419

5.  Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Babikir Kheiri; Mohammed Osman; Ahmed Abdalla; Tarek Haykal; Mahmoud Barbarawi; Yazan Zayed; Michael Hicks; Sahar Ahmed; Ghassan Bachuwa; Mustafa Hassan; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 6.  Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.

Authors:  Mattia Galli; Francesco Franchi; Fabiana Rollini; Larisa H Cavallari; Davide Capodanno; Filippo Crea; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2021-05-26       Impact factor: 4.108

Review 7.  Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.

Authors:  Sherry-Ann Brown; Naveen Pereira
Journal:  J Pers Med       Date:  2018-01-30

8.  Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial.

Authors:  Dagmar F Hernandez-Suarez; Kyle Melin; Frances Marin-Maldonado; Hector J Nunez; Ariel F Gonzalez; Lorena Gonzalez-Sepulveda; Sona Rivas-Tumanyan; Hetanshi Naik; Gualberto Ruaño; Stuart A Scott; Jorge Duconge
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

9.  Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study.

Authors:  Hefei Fu; Pan Hu; Chunmei Ma; Fei Peng; Zhiyi He
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.